Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
alpha-synuclein
Alzheimer's disease
amantadine
anosmia
aphasia
aphasia, progressive, primary
asymptomatic
atypical
autonomic dysfunction
Babinski sign
basal ganglia, infarction
behavioral disorder
biologic markers
bladder dysfunction
brain atrophy
brain biopsy
brain transplantation
carotid artery disease
carotid artery disease, asymptomatic
carotid artery disease, medical management
carotid artery stenosis
CAT scan, emission
CAT scan, emission, abnormal
cerebral infarction
cerebral infarction, subcortical
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrovascular accident
cerebrovascular disease
cerebrovascular disease, surgical treatment of
chromosome 17
chromosome 6
Clinical Pathologic Conference(C.P.C.)
complications
compulsivity
constipation
controversies in neurology
degenerative diseases of CNS
delusion
dementia
dementia, age at onset
dementia, familial
dementia, frontal lobe type
dementia, frontotemporal
dementia, presenile
dementia, rapidly progressive
deprenyl
depression
diagnostic criteria
diet
differential diagnosis
disability rating scale, neurological
disability, neurological
dopamine agonist
dopamine receptor
dyskinesia
dyskinesia, drug induced
dystonia
endarterectomy, carotid
enzyme inhibition
epidemiology of neurology
executive dysfunction
familial
farmer
fetal tissue
fetus
fluency
frontal lobe, pathologic signs of
frontotemporal dementia, behavioral variant
gait disorder
gene
gene mutation
genetic neurologic disorders
genetic testing
grasp reflex
gray matter
hallucination
head injury
hemiparesis
heralding manifestation
herbicide
highly active antiretroviral therapy
hormone replacement
human genome
human immunodeficiency virus type 1
hyperosmia
hyperreflexia
hypersomnia
hyposmia
hypotension, systemic
imbalance
impulsivity
inclusion bodies
inflexibility, mental
insecticides
intellectual deficit
L-dopa
L-dopa, delayed treatment in Parkinsonism
L-dopa, drug interactions with and side effects of
Lewy body
Lewy body disease, diffuse
life expectancy
lobar atrophy
loss of sympathy
manganese intoxication
misdiagnosis
monoamine oxidase inhibitors
mood change
mortality
motor neuron disease
movement disorder
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, diffusion tensor
MRI, functional
neurofibrillary degeneration
neuroleptic, atypical
neurologic complications of, surgery
neurologic disease
neurologic disease, diagnoses of
neurologic symptoms
neuropathology
neuropathology, brain
neuroprotective agents
neurotoxic
neurotoxin
obsessive-compulsive disorder
old age, neurology of
orthostatic hypotension
pain, increased response
pallidotomy
Parkinson disease
Parkinson disease, acute onset
Parkinson disease, arteriosclerotic
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, duration
Parkinson disease, early symptoms
Parkinson disease, etiology of
Parkinson disease, familial
Parkinson disease, fluctuations in
Parkinson disease, freezing phenomena in
Parkinson disease, hemiparesis in
Parkinson disease, heterogeneity of
Parkinson disease, late onset
Parkinson disease, L-dopa nonresponsive
Parkinson disease, misdiagnosis
Parkinson disease, mode of onset
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, presymptomatic detection
Parkinson disease, prognosis of
Parkinson disease, progression
Parkinson disease, rapid progression
Parkinson disease, surgical treatment of
Parkinson disease, transient
Parkinson disease, treatment of
Parkinson disease, unilateral
Parkinson disease, wearing off
Parkinson disease, young onset
Parkinsonism syndrome
Parkinsonism-dementia complex
pathologic reflex
pergolide
personality change
Pick bodies
Pick's disease
polymerase chain reaction
pramipexole
preclinical
premarin
prevention of neurologic disorders
PRKN gene
prognosis
progressive neurologic disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
quetiapine
radiotracer imaging
rasagiline
release phenomena
REM sleep
REM sleep behavior disorder
revascularization, surgical
review article
risk factors
senile plaques
sinemet
single photon emission computed tomography
sleep
sleep pathology and physiology
smell
Smell Identification Test
solvent
speech disorder
stereotyped behavior
stimulation, deep brain
substantia nigra
syncope
synucleinopathy
tau protein
tauopathy
temporal lobe, atrophy
tonic foot response
trauma
treatment of neurologic disorder
tremor
tremor, thalamic stimulation for suppression of
trichloroethylene
ultraprocessed foods
walking, difficulty with
watershed infarcts
weight loss
wheelchair
word-finding difficulty
Showing articles 50 to 100 of 3071 << Previous Next >>

Preclinical Detection of Parkinson's Disease
Neurology Suppl 2, 41:5-921991., Koller,W.C.&Langston,J.W., 1991

A Large Kindred with Autosomal Dominant Parkinson's Disease
Ann Neurol 27:276-282, Golbe,L.I.,et al, 1990

Effect of Age at Onset on Progression and Mortality in Parkinson's Disease
Neurol 39:1187-1190, Diamond,S.G.,et al, 1989

A Comparison of Clinical and Pathological Features of Young-and Old-Onset Parkinson's Disease
Neurol 38:1402-1406, Gibb,W.R.G.&Lees,A.J., 1988

Elevated Manganese Levels Associated with Dementia & Extrapyramidal Signs
Neurol 27:213, Banta,R.G.,et al, 1977

Rapidly Progressive Frontotemporal Dementia with Amytrophic Lateral Sclerosis in an Elderly Female
Cureus doi:10.7759/CUREUS.32182, Sweedan,Y.G.,et al, 2025

Juvenile-Onset Dopa-Responsive Dystonia-Until It Isnt
Neurol 104:e213436, Paredes,N.C.,et al, 2025

Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease
Ann Neurol 96:1086-1091, Fadda,G.,et al, 2024

A 30-Year-Old Woman Presenting with Rapidly Progressive Dementia and Extreme Hypoglycorrhachia
Neurol 102:e209188, Bai,X.,et al, 2024

A 51-Year-Old Woman with Abnormal Corups Callosum Signal
JAMA Neurol 81:192-193, Xie,N. & Sun, Q, 2024

Alzheimers Disease Biomarkers - Timing is Everything
NEJM 390:761-763, Mayeux,R., 2024

Tau Positron Emission Tomography for Predicting Dementia in Individuals with Mild Cognitive Impairment
JAMA Neurol 81:845-856, Groot,C.,et al, 2024

Revised Criteria for Diagnosis and Staging of Alzheimers Disease: Alzheimers Association Workgroup
Alzheimers Dement 20:5143-5169, Jack,Jr.,C.R.,et al, 2024

Thrombectomy for Acute Ischaemic Stroke Without Advanced Imaging
Lancet 402:1724-1725, Kippel,D.W.J. & Roozenbeek, B, 2023

Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023

Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke with Large-Vessel Occlusion
JAMA Neurol 79:22-31, Nguyen, T.N.,et al, 2022

Thrombectomy for Anterior Circulation Stroke Beyond 6 h from Time Last Known Well (AURORA): A Systematic Review and Individual Patient Data Meta-Analysis
Lancet 399:249-258, Jovin, T.G.,et al, 2022

The Phenotypic Continuum of ATP1A3-Related Disorders
Neurol 99:e1511-e1526, Vezyroglou,A., et al, 2022

Sporadic Creutzfeldt-Jakob Disease in a Very Young Person
Neurol 97:813-816,801, Appleby, B.S.,et al, 2021

Vitamin B12 Deficiency in a 29-Year-Old Woman
Neurol 97:e643-e646, Huddar, A.,et al, 2021

Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinsons Disease
NEJM 383:2501-2513,2582, Martinez-Fernandez, R.,et al, 2020

Diffusion-Weighted MRI in Transient Global Amnesia and its Diagnositc Implications
Neurol 95:e206-e212, Szabo, K.,et al, 2020

Machine Learning Approach to Identify Stroke Within 4.5 Hours
Stroke 51:860-866, Lee, H.,et al, 2020

A 54-year-old man with Dyspnea and Muscle Weakness
Neurol 92:e1136-e1140, Chertcoff, A.,et al, 2019

Cerebral Atrophy and Leukoencephalopathy in a Young Man Presenting with Encephalitic Episodes
JAMA Neurol 75:1563-1564, Xiao, F.,et al, 2018

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
NEJM 379:1017-1027, Chitnis, T.,et al, 2018

Use of Newer Disease-Modifying Therapies in Pediatric Multiple Sclerosis in the US
Neurol 91:e1778-e1787, Krysko, K.M.,et al, 2018

Practice Guide Update Summary: Mild Cognitive Impairment
Neurol 90:126-135, Petersen, R.C.,et al, 2018

Intractable Epilepsy and Progressive Cognitive Decline in a Young Man
JAMA Neurol 74:737-740, Cohen, A.L.,et al, 2017

Odor Identification as a Biomarker of Preclinical AD in Older Adults at Risk
Neurol 89:327-335, Lafaille-Magnanm, M.E.,et al, 2017

Introduction of a Dedicated Emergency Department MR Imaging Scanner at the Barrow Neurological Institute
AJNR 38:1480-1485, Buller, M. & Karis, JP, 2017

Clinical Imaging Factors Associated with Infarct Progression in Patients with Ischemic Stroke During Transfer for Mechanical Thrombectomy
JAMA Neurol 74:1361-1367,1298, Boulouis, G.,et al, 2017

A Young Man with Progressive Language Difficulty and Early-Onset Dementia
JAMA Neurol 73:595-599, Botha, H.,et al, 2016

Non-Alzheimers Dementia 2 Lewy Body Dementias
Lancet 386:1683-1697, Walker, Z.,et al, 2015

Prevalence of Cerebral Amyloid Pathology in Persons without Dementia
JAMA 313-1924-1938,1913, Jansen, W.J.,et al, 2015

Plasma Levels of Apolipoprotein E and Risk of Dementia in the General Population
Ann Neurol 77:301-311, Rasmussen, K.L.,et al, 2015

"Noncognitive" Symptoms of Early Alzheimer Disease
Neurol 84:617-622, Masters, M.C.,et al, 2015

A Case of Early-Onset Rapidly Progressive Dementia
JAMA Neurol 71:1445-1449, Cachia, D.,et al, 2014

Progressive Neuropsychiatric Symptoms and Motor Impairment
JAMA Neurol 71:794-798, Ghadiri, M.,et al, 2014

Predicting Alzheimer Disease with �-Amyloid Imaging: Results from the Australian Imaging, Biomarkers, and Lifestyle Study of Ageing
Ann Neurol 74:905-913, Rowe, C.C.,et al, 2013

Frontotemporal Dementia
BMJ 347:f4827, Warren, J.D.,et al, 2013

An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment
AJNR 34:2075-2082, Desikan, R.S.,et al, 2013

Lifelong Management of Amyloid-Beta Metabolism to Prevent Alzheimers Disease
NEJM 367:864-866, Gandy, S., 2012

Clinical and Biomarker Changes in Dominantly Inherited Alzheimers Disease
NEJM 367:795-804,864, Bateman, R.J.,et al, 2012

Treat Alzheimer Disease Before It Is Symptomatic
Arch Neurol 68:1237-1238, , 2011

Longitudinal Change of Biomakers in Cognitive Decline
Arch Neurol 68:1257-1266,1237, Lo, R.Y.,et al, 2011

Changing Concepts of Alzheimer Disease
JAMA 35:2458-2459, McKhann, G.M., 2011

A Comparison of MRI Criteria for Diagnosing Pediatric ADEM and MS
Neurol 74:1412-1415, 1404, Ketelslegers,I.A., et al, 2010

Clinicopath Conf, Rapid-Onset-Dystonia-Parkinsonism Due to a Mutation in the ATP1A3 Gene
NEJM 362:2213-2219, Case 17-2010, 2010

Early Alzheimers Disease
NEJM 362:2194-2201, Mayeux,R., 2010



Showing articles 50 to 100 of 3071 << Previous Next >>